Glycine suppresses kidney calcium oxalate crystal depositions via regulating urinary excretions of oxalate and citrate
- PMID: 33772775
- DOI: 10.1002/jcp.30370
Glycine suppresses kidney calcium oxalate crystal depositions via regulating urinary excretions of oxalate and citrate
Abstract
An abnormal urine composition is a key reason for kidney stone formation, but little is known about the roles of small metabolites in the urine during kidney stone formation. Here, we found urine glycine in patients with kidney calcium oxalate (CaOx) stone was significantly lower than that in healthy people via 1 H NMR spectra detection, and investigated the role and underlying mechanism of glycine in the regulation of CaOx stone formation. Our results showed that glycine could significantly attenuate ethylene glycol-induced CaOx crystal depositions in rat kidney via decreasing urine oxalate and increasing urine citrate. Mechanism studies revealed that glycine could decrease urine oxalate through downregulating Slc26a6 expression, whereas increase urine citrate via inhibiting Nadc1 expression. Moreover, glycine decreased the protein expression of both Slc26a6 and Nadc1 via increasing the expression of miRNA-411-3p, which directly bound to the 3'-untranslated regions of Slc26a6 and Nadc1 messenger RNAs, in vitro and in vivo. Together, our results revealed a novel role of glycine in the regulation of kidney CaOx crystal formation and provided a potential target for the treatment of kidney CaOx stone.
Keywords: calcium oxalate stone; citrate; glycine; miRNA-411-3p; oxalate.
© 2021 Wiley Periodicals LLC.
Comment in
-
Uro-Science.J Urol. 2022 Jun;207(6):1341-1342. doi: 10.1097/JU.0000000000002656. Epub 2022 Mar 18. J Urol. 2022. PMID: 35300509 No abstract available.
References
REFERENCES
-
- Azad, R. K. , & Shulaev, V. (2019). Metabolomics technology and bioinformatics for precision medicine. Briefings in Bioinformatics, 20(6), 1957-1971. https://doi.org/10.1093/bib/bbx170
-
- Banales, J. M. , Iñarrairaegui, M. , Arbelaiz, A. , Milkiewicz, P. , Muntané, J. , Muñoz-Bellvis, L. , La Casta, A. , Gonzalez, L. M. , Arretxe, E. , Alonso, C. , Martínez-Arranz, I. , Lapitz, A. , Santos-Laso, A. , Avila, M. A. , Martínez-Chantar, M. L. , Bujanda, L. , Marin, J. J. G. , Sangro, B. , & Macias, R. I. R. (2018). Serum metabolites as diagnostic biomarkers for cholangiocarcinoma, hepatocellular carcinoma, and primary sclerosing cholangitis. Hepatology, 70(2), 547-562. https://doi.org/10.1002/hep.30319
-
- Cai, C. , Mai, Z. , Deng, T. , Zhao, Z. , Zhu, W. , Wen, Y. , Duan, X. , Wu, W. , & Zeng, G. (2018). Impact of dyslipidemia on 24 h urine composition in adults without urolithiasis. Lipids in Health and Disease, 17, 250. https://doi.org/10.1186/s12944-018-0899-x
-
- Cheng, S. , Shah, S. H. , Corwin, E. J. , Fiehn, O. , Fitzgerald, R. L. , Gerszten, R. E. , Illig, T. , Rhee, E. P. , Srinivas, P. R. , Wang, T. J. , & Jain, M. (2017). Potential impact and study considerations of metabolomics in cardiovascular health and disease: A scientific statement from the American Heart Association. Circiculation: Cardiovascular Genetics, 10(2), e000032. https://doi.org/10.1161/HCG.0000000000000032
-
- Ding, Y. , Svingen, G. F. T. , Pedersen, E. R. , Gregory, J. F. , Ueland, P. M. , Tell, G. S. , & Nygård, O. K. (2015). Plasma glycine and risk of acute myocardial infarction in patients with suspected stable angina pectoris. Journal of the American Heart Association, 5(1), e002621. https://doi.org/10.1161/JAHA.115.002621
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical